LONDON–(BUSINESS WIRE)– FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o
Month: September 2026
CARROLLTON, Ga., September 25, 2026 /3BL/ – Southwire Company, LLC, Georgia Power, and nonprofit infrastructure innovator The Ray have joined forces on an innovative land management initiative in Carroll County, transforming a traditional energy transmission corridor into a thriving native wildflower meadow that supports pollinators, enhances biodiversity, and demonstrates a more sustainable approach to managing utility rights-of-way.
Planted this spring near Southwire’s Carrollton facilities, the newly established meadow reimagines how rights-of-way under high-voltage utility lines can be utilized. By replacing traditional vegetation management practices with a carefully curated mix of native plants, the project creates a vibrant, diverse habitat that provides season-long food, shelter, and nesting resources for native bees, butterflies, hummingbirds, and other wildlife.
“This partnership with Southwire and The Ray shows how utility rights-of-way can support grid reliability while also providing habitat for pollinators and wildlife. Projects like this show how thoughtful growth and conservation can go hand in hand, creating value for the grid, native species, and customers across our state.”
— Jennifer McNelly, VP of Environmental Affairs, Georgia Power
Beyond supporting local biodiversity, native meadow systems offer distinct operational advantages. Deep-rooted native plants naturally suppress unwanted brush, lower long-term maintenance costs by reducing mowing frequency, and aid in soil stabilization. These revitalized rights-of-way effectively serve as biological pathways, connecting fragmented rural landscapes and allowing wildlife to travel safely through urbanized zones without compromising energy grid reliability or safety access.
“Southwire is glad to partner with Georgia Power and The Ray on this project. Pollinators are in decline due to habitat loss and other factors, and this project will transform unused land for a beneficial purpose. We recently published our 2025 report entitled The Power to Transform, which outlines Southwire’s commitment to responsible practices and corporate stewardship. We’re excited about how this project makes a difference in these efforts.”
— Bo Quick, VP of Corporate Sustainability and Strategy, Southwire
The Carrollton habitat project is a practical, nationally scalable blueprint for how energy providers, industrial leaders, and government entities can co-create functional, nature-positive landscapes within existing working infrastructure.
About Southwire
Southwire Company, LLC is one of North America’s leading wire and cable companies. The $9.7B organization is made up of more than 9,000 team members across the globe who unite as ONE Southwire each and every day to serve each other, their customers and their communities. Southwire and its subsidiaries provide solutions including building wire and cable, metal-clad cable, utility products, portable and electronic cord products and OEM wire products. In addition, Southwire offers electrical products, engineered solutions and a variety of field support services. For more on Southwire’s products and solutions, its community involvement and its vision of sustainability, visit www.southwire.com.
About Georgia Power
Georgia Power is the largest electric subsidiary of Southern Company (NYSE: SO), America’s premier energy company. Value, Reliability, Customer Service and Stewardship are the cornerstones of the company’s promise to 2.8 million customers in all but four of Georgia’s 159 counties. Committed to delivering clean, safe, reliable and affordable energy, Georgia Power maintains a diverse, innovative generation mix that includes nuclear, coal and natural gas, as well as renewables such as solar, hydroelectric and wind. Georgia Power offers rates below the national average, focuses on delivering world-class service to its customers every day and the company is recognized by J.D. Power as an industry leader in customer satisfaction. For more information, visit www.GeorgiaPower.com and connect with the company on Facebook (Facebook.com/GeorgiaPower), X (X.com/GeorgiaPower), and Instagram (Instagram.com/ga_power).
About The Ray
The Ray is a nonprofit organization that reimagines infrastructure to be safer, cleaner, and more productive. We partner with all levels of government to drive innovation in energy and mobility, improving capacity, production, and longevity. Advancing technologies with industry leaders, we’re the only nonprofit in the United States using geospatial analysis for right-of-way utilization, research-based practices, and cutting-edge safety systems to improve transportation.
Media Contacts:
The Ray
Dallen McLemore, Communications Specialist
229.449.6168 | dallen@theray.org | @TheRayHighway
Southwire
Ashley Bush, Sr. Director of Communications
LONDON–(BUSINESS WIRE)– DB ETC PLC Dated: 25 September 2026 COMPANY ANNOUNCEMENT Immediate Release 25 September 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 24 September 2026 Series ISIN Currency Value per Se
LONDON–(BUSINESS WIRE)– Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Rising Dividend Achievers UCITS ETF 24.09.2026 EDVY.LN IE000CPG9HG3 50,002.00 EUR 1,135,550.45 22.710
MISSISSAUGA, Ontario, Sept. 25, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named as one of Canada’s Top Growing Companies for 2026 by The Globe and Mail’s Report on Business magazine. BioSyent ranked 343 on the list based on its three-year revenue growth of 54% (2022 – 2025) and is listed in the ‘Consumer’ category.
“We are very proud to have been recognized as one of Canada’s Top Growing Companies,” said René Goehrum, President and CEO of BioSyent. “With the support of our team and the continued trust of patients and healthcare providers, we have continued to execute on one of BioSyent’s key strategic priorities of profitable growth, with Q2 2026 marking the 64th consecutive profitable quarter for the Company.”
The full 2026 ranking of Canada’s Top Growing Companies is available online at globeandmail.com and will appear in the October issue of Report on Business magazine.
About BioSyent Inc.
Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty healthcare products company focused on acquiring or in-licensing, marketing and distributing innovative pharmaceutical and oral health products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its Pharmaceutical and Oral Health businesses, both in Canada and internationally.
As of the date of this press release, the Company has 11,232,335 common shares outstanding.
For a direct market quote for the TSX Venture Exchange and other Company financial information please visit www.tmxmoney.com.
For further information please contact:
Mr. René C. Goehrum
President and CEO
BioSyent Inc.
E-Mail: investors@biosyent.com
Phone: 905-206-0013
Web: www.biosyent.com
This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements. Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
LONDON–(BUSINESS WIRE)– Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF – December 24.09.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,429,483.10 28.589
SHANGHAI, China, Sept. 25, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, has released its 2026 interim report, highlighting continued progress in its “AI + Chronic Disease Services” strategy as the Company advances its positioning as a full-lifecycle personal health service partner.
In the first half of 2026, Fangzhou recorded revenue of RMB1.8245 billion, up 22.2% year-on-year, while adjusted net profit increased 6.4% to RMB18.7 million. The Company’s cumulative registered users exceeded 59.8 million, with average monthly active users rising 23.1% to 14.7 million. Its network of registered physicians expanded to 282,000.
Fangzhou continued to accelerate the deployment of AI across chronic disease services, addressing persistent challenges in out-of-hospital management, including treatment adherence, patient follow-up and care costs. Built on its proprietary “XingShi” Large Language Model (“XS LLM”), its AI Health Manager and AI Medication Assistant provide 24/7 support, medication reminders and personalized health management based on patients’ evolving needs, helping shift chronic care from passive response toward proactive, continuous support.
On the physician side, AI pre-consultation, AI-assisted diagnosis and the AI Academic Assistant help reduce repetitive administrative workloads and improve service efficiency. Digital tools also support post-consultation follow-up, allowing professional medical services to reach more patients. Internally, Fangzhou has extended AI applications into supply-chain management, including inventory allocation and last-mile delivery, to improve operational efficiency.
The Company also continued strengthening the industry ecosystem underpinning its healthcare services. During the period, Fangzhou worked with more than 1,800 suppliers and 1,000 pharmaceutical companies, while prescription drugs accounted for 83.1% of platform GMV. Strategic collaborations with pharmaceutical companies, including Youcare Pharmaceutical and Tenry Pharma, supported the launch of innovative medicines, helping connect pharmaceutical innovation with patients through Fangzhou’s digital healthcare infrastructure.
Leveraging its patient network and digital engagement capabilities, Fangzhou is also expanding its role as a digital collaboration partner for pharmaceutical companies. Across key chronic disease specialties, the platform integrates medication guidance, patient education and full-course disease management into everyday services, supporting broader access to innovative treatments while strengthening its professional chronic care capabilities.
In the second half of 2026, Fangzhou will further advance its strategy as a full-lifecycle personal health service partner, expanding the XS LLM and its portfolio of AI-powered services across more healthcare scenarios. The Company will also deepen collaboration with pharmaceutical partners and strengthen specialty-care capabilities, helping to build a reliable, patient-centered health service ecosystem that supports patients throughout their health journey.
About Fangzhou Inc.
Fangzhou Inc. (HKEX: 06086) is China’s leading online chronic disease management platform, serving 59.8 million registered users and 282,000 physicians (as of June 30, 2026). The Company specializes in delivering tailored medical care and AI‑enabled precision medicine solutions. For more information, visit https://investors.jianke.com.
Media Contact
For further inquiries or interview requests, please contact:
Xingwei Zhao
Director of Public Relations
Email: pr@jianke.com
Disclaimer: This press release contains forward‑looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements.
LONDON–(BUSINESS WIRE)– DB ETC PLC Dated: 25 September 2026 COMPANY ANNOUNCEMENT Immediate Release 25 September 2026 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 04 – Xtrackers Physical Silver EUR Hedged ETC 459 671 23 Septembe
Oma Savings Bank Plc, stock exchange release, 25 September 2026 at 4.30 p.m. (EEST), other information disclosed to the rules of the exchange
Oma Savings Bank Plc issues a covered bond of EUR 200 million as part of a bond program
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES, THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
Oma Savings Bank Plc (“OmaSp” or the “Company”) issues a covered bond of EUR 200 million. The maturity date of the bond is 2 October 2029, and the loan has a floating interest rate. The ISIN code of the bond is FI4000615059.
The loan issuance will take place under OmaSp’s EUR 4 billion bond program. On 1 September 2026, the Finnish Financial Supervisory Authority approved the base prospectus in respect of OmaSp’s bond program, and the supplement thereto on 21 September 2026.
The base prospectus, the supplement and the final terms of the bond are available in English on the Company’s website at https://www.omasp.fi/investors.
OmaSp has submitted an application for the bond to be admitted to trading on the regulated market maintained by Nasdaq Helsinki Ltd.
Oma Savings Bank Plc
Additional information:
Karri Alameri, CEO, tel. +358 20 758 3040, karri.alameri@omasp.fi
Sarianna Liiri, CFO, tel. +358 40 835 6712, sarianna.liiri@omasp.fi
Pirjetta Soikkeli, CCO, tel. +358 40 750 0093, pirjetta.soikkeli@omasp.fi
DISTRIBUTION:
Nasdaq Helsinki Ltd
Major media
www.omasp.fi
OmaSp is a solvent and profitable Finnish bank. About 600 professionals provide nationwide services through OmaSp’s 48 branch offices and digital service channels to over 200,000 private and corporate customers. OmaSp focuses primarily on retail banking operations and provides its clients with a broad range of banking services both through its own balance sheet as well as by acting as an intermediary for its partners’ products. The intermediated products include credit, investment and loan insurance products. OmaSp is also engaged in mortgage banking operations.
OmaSp core idea is to provide personal service and to be local and close to its customers, both in digital and traditional channels. OmaSp strives to offer premium level customer experience through personal service and easy accessibility. In addition, the development of the operations and services is customer oriented. The personnel is committed and OmaSp seeks to support their career development with versatile tasks and continuous development. A substantial part of the personnel also own shares in OmaSp.
AS LHV Group announces that during the period 18 to 24 September 2026, it has acquired the company’s own shares on the Nasdaq Tallinn Stock Exchange as follows:
| Date | Aggregated volume (pcs) | Weighted average price per day (EUR) |
| 18.09.2026 | 19,800 | 3.31 |
| 21.09.2026 | 20,100 | 3.31 |
| 22.09.2026 | 26,800 | 3.30375 |
| 23.09.2026 | 20,400 | 3.295 |
| 24.09.2026 | 26,800 | 3.2925 |
LHV Group is acquiring its own shares based on the resolution of the company’s general meeting of shareholders held on 26 March 2025, and under the conditions decided by the Supervisory Board. The authorized agent for the transactions is AS LHV Pank. Summary data of the acquisitions will be disclosed no later than on the seventh trading day after the transaction and will be made available to the Financial Supervision and Resolution Authority, via the Nasdaq Tallinn system, and on LHV Group’s investor website.
LHV Group is the largest domestic financial group and capital provider in Estonia. LHV Group’s main subsidiaries are LHV Pank, LHV Varahaldus, LHV Kindlustus and LHV Bank Limited. The Group employs nearly 1,200 people. LHV’s banking services are used by more than 514,000 customers, LHV-managed II pillar pension funds have 105,000 active customers and LHV Kindlustus provides insurance protection to 244,000 customers. LHV Bank, a subsidiary of LHV Group, holds a UK banking licence and offers banking services to international financial technology companies, loans to small and medium-sized enterprises and retail banking services.
Investor Relations
Sten Hans Jakobsoo
Head of Investor Relations and Corporate Development
Email: stenhans.jakobsoo@lhv.ee
Communications
Paul Pihlak
Head of Communications
Email: paul.pihlak@lhv.ee
